Status:

SUSPENDED

Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Alcoholic Patient

Carcinological Surgery ORL

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The principal objective is to evaluate the analgesic effectiveness of the systemic ketamine on the control of the pain (average consumption of morphine at 48 hours) at the alcool-dependent patient, in...

Detailed Description

The principal objective is to evaluate the analgesic effectiveness of the systemic ketamine on the control of the pain (average consumption of morphine at 48 hours) at the alcool-dependent patient, in...

Eligibility Criteria

Inclusion

  • patient alcohol-dependent having to undergo a carcinological surgery ORL with tracheotomy or tracheostomy, ASA 1-3

Exclusion

  • refusal of the patient
  • counter-indications with the treatments,
  • urgency
  • the specific clinical context (final neoplasy, reanimation)
  • the treatments for chronic pain containing morphinic

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2008

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT00329394

Start Date

April 1 2006

End Date

September 1 2008

Last Update

October 8 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clermont-Ferrand University Hospital

Clermont-Ferrand, France, 63000